$1.16
+0.16 (+16.00%)
Open$0.98
Previous Close$1.00
Day High$1.33
Day Low$0.98
52W High$1.45
52W Low$0.38
Volume—
Avg Volume60.0K
Market Cap25.30M
P/E Ratio—
EPS$-5.98
SectorN/A
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,244.0% upside
Current
$1.16
$1.16
Target
$15.59
$15.59
$14.04
$15.59 avg
$21.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.22M | 20.30M | 17.77M |
| Net Income | 1.18M | 1.16M | 1.21M |
| Profit Margin | 6.1% | 5.7% | 6.8% |
| EBITDA | 2.01M | 2.27M | 2.16M |
| Free Cash Flow | 1.07M | 1.22M | 952.2K |
| Rev Growth | +20.2% | +6.7% | +16.3% |
| Debt/Equity | 0.67 | 0.58 | 0.78 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.59 | +12.61% | — | 4.06B |
| PICS | Pics Nv | $10.45 | +5.34% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.97 | -0.10% | — | 656.41M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.18B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.56 | -0.14% | 63.3 | 608.01M |
| CEPF | Cantor Equity Partners-Cl A | $10.19 | -0.10% | 356.1 | 583.50M |